## Abstract Next to chromosome 22 anomalies, deletions of the short arm of chromosome I have previously been described as the most frequent alteration detected by cytogenetic analysis of meningiomas. To determine the incidence of these deletions, we have analyzed a series of 50 meningiomas for the
Allelic loss at chromosome band 8p21.3-p22 is associated with progression of hepatocellular carcinoma
β Scribed by Mitsuru Emi; Yoshiyuki Fujiwara; Hiroyuki Ohata; Hitoshi Tsuda; Setsuo Hirohashi; Morio Koike; Michiko Miyaki; Morito Monden; Yusuke Nakamura
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 444 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1045-2257
No coin nor oath required. For personal study only.
β¦ Synopsis
Human hepatocellular carcinomas (HCC) frequently show loss of heterozygosity at loci on the short arm of chromosome 8. To define a region on 8p commonly deleted in HCC, we used 20 restriction fragment length polymorphism markers t o carry out detailed deletion mapping in 142 HCC. Of the I24 informative cases, 56 (45%) showed allelic losses in tumors. While more than half of them had lost alleles at every locus on the short arm, others lost them partially or interstitially. Common deletion of an 8-cM region flanked by cMSR-32 and cC18-245, at 8p21.3-p22, suggested the presence of a tumor suppressor gene@) in this interval. Correlation between allelic losses on 8p and clinicopathological parameters were examined in the 5 I cases for which detailed clinical data were available; allelic losses on 8p were observed in none of five tumors at stage T I (O%), nine of 20 tumors at stage T2 (45%), and I7 of 26 tumors at stage T3/T4 (65%). A higher frequency of allelic losses on 8p was observed in poorly differentiated tumors (10/14,7 I %) than in well differentiated tumors (3/ 13, 23%). The association of allelic losses on 8p with advanced clinical stage and poor differentiation implies that loss or inactivation of a tumor suppressor gene@) on 8p may play a role in the progression of HCC. Genes Chrom Cancer 7:/52-157 (1993).
π SIMILAR VOLUMES
observed in a wide variety of human tumors. Cytogenetic and molecular genetic studies in breast carcinomas
## BACKGROUND. Alterations in chromosome 1 are common in human malignancies. The frequency of loss of heterozygosity (LOH) on chromosome 1 in cervical carcinoma and its clinical significance are not clearly understood.
Papillary renal cell carcinomas (RCCs) have characteristic clinical and morphological features that separate them from the more common clear cell RCCs. The details of the molecular changes in papillary RCC progression are not well understood. In this study, four highly polymorphic microsatellite mar
To identify the putative tumor-suppressor gene (TSG) involved in transitional-cell carcinoma (TCC) of the urinary bladder, we undertook an allelotyping analysis in 48 cases of TCC. Relatively high percentages of allelic loss were found in 2p (5 of 23, 21.7%), 8p (9 of 21, 42.9%), 9p (4 of 20, 20.0%)
In this study, 105 non-papillary renal cell carcinomas (RCCs) have been examined for allelic loss at the chromosome 8p12-21.1, 9p21, and 14q24.2-qter regions, each by two highly polymorphic microsatellites. Loss of heterozygosity (LOH) was detected at both chromosome 8p and 9p in 33 per cent of the